Skip to main content

Table 5 Treatment-emergent adverse events reported immediately post-intervention. CADSS = clinician administered dissociative states scale

From: Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates

 

Arm 1 NTX

(n = 12)

Arm 2 KET

(n = 12)

Tolerable

n (%)

Distressing

n (%)

Tolerable

n (%)

Distressing

n (%)

Lightheadedness

   

1 (8.3%)

Fatigue

1 (8.3%)

   

Arm pain

1 (8.3%)

 

1 (8.3%)

 

Nausea

  

1 (8.3%)

 

Floating

  

1 (8.3%)

 

Hot flashes

1 (8.3%)

   

Dry mouth

1 (8.3%)

   

Tingling

1 (8.3%)

   

Body tightness

  

1 (8.3%)

 

Lip numbness

   

1 (8.3%)

Blurred vision

  

1 (8.3%)

 

Tingling

  

1 (8.3%)

 

CADSS Score (mean, sd)

 

20.31 (16.62)

Back to article page

Addiction Science & Clinical Practice

ISSN: 1940-0640